PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Manipal Health Enterprises Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Manipal Health Enterprises Limited's yearly results, compared with Healthcare companies in India. Tap ? on any ratio for what it means.

What stands out

  • Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 98% of Healthcare companies in India.
  • Tangible Assets Ratio: Of every ₹100 the company owns, ₹58 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 95% of Healthcare companies in India.

Where ₹100 of sales goes

₹82Operating costs₹11Interest₹6.0Net profit

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Data incomplete

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

—

Data incomplete

Growth Efficiency Ratio

—

Data incomplete

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

3.4×

Debt due within a year is covered 3.4 times by its yearly operating cash.

Higher than 67% of Healthcare companies in India.

Cash Cushion Ratio

−12%

Debt, after subtracting cash, equals 12% of its market value (net debt).

Lower than 83% of Healthcare companies in India.

Tangible Assets Ratio

58%

Of every ₹100 the company owns, ₹58 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 95% of Healthcare companies in India.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 98% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

—

Data incomplete

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Manipal Health Enterprises Limited owes ₹0.65 for every ₹1 it owns. Net profit rose 28% in the year to Mar 2026.

Compared with Healthcare companies in India · latest annual results Mar 2026.

P/E ratio

129.2

Investors pay ₹129.2 for every ₹1 of Manipal Health Enterprises Limited's yearly profit, higher than 93% of Healthcare companies in India.

P/B ratio

9.76

The share price is 9.76 times Manipal Health Enterprises Limited's book value per share, higher than 82% of Healthcare companies in India.

Market cap

₹82,264 Cr

The total market value of all of Manipal Health Enterprises Limited's shares at today's price (share price × number of shares), larger than 93% of Healthcare companies in India. PosiCap size class: Meso Cap.

Net worth (book value)

₹8,426 Cr

What Manipal Health Enterprises Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹64.06

Net worth divided by the number of shares. The share price of ₹625.40 is 9.8 times this, which is the P/B above.

Return on equity (ROE)

6.8%

Manipal Health Enterprises Limited earned 6.8% on its shareholders' money over the last year, lower than 79% of Healthcare companies in India.

Owes vs Owns

0.65×

Manipal Health Enterprises Limited owes ₹0.65 for every ₹1 it owns (moderate), higher than 95% of Healthcare companies in India.

Dividend yield

None

Manipal Health Enterprises Limited does not currently pay a dividend.

Revenue growth

+18%

Revenue rose 18% in the year to Mar 2026.

Profit growth

+28%

Net profit rose 28% in the year to Mar 2026.

Profit margin

6.0%

Manipal Health Enterprises Limited keeps ₹6 of every ₹100 of revenue as net profit.

Cash quality

3.2×

Cash from Manipal Health Enterprises Limited's business was 3.2× its reported profit in the year to Mar 2026 — its profit turned into cash.

Interest cover

1.7×

Manipal Health Enterprises Limited's operating profit covered its interest costs 1.7 times in the year to Mar 2026.

Cash vs debt

Net debt

Manipal Health Enterprises Limited had ₹10,052 Cr more debt than cash (net debt) at Mar 2026.

Questions

What is Manipal Health Enterprises Limited's P/E ratio?

Investors pay ₹129.2 for every ₹1 of Manipal Health Enterprises Limited's yearly profit, higher than 93% of Healthcare companies in India.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Manipal Health Enterprises Limited: ₹82,264 Cr ÷ ₹8,426 Cr (31 Mar 2026) = 9.8.

What is Manipal Health Enterprises Limited's return on equity?

Manipal Health Enterprises Limited earned 6.8% on its shareholders' money over the last year, lower than 79% of Healthcare companies in India.

How much does Manipal Health Enterprises Limited owe compared with what it owns?

Manipal Health Enterprises Limited owes ₹0.65 for every ₹1 it owns (moderate), higher than 95% of Healthcare companies in India.

Does Manipal Health Enterprises Limited pay a dividend?

No. Manipal Health Enterprises Limited does not currently pay a dividend.

Is Manipal Health Enterprises Limited's revenue growing?

Revenue rose 18% in the year to Mar 2026.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.